IKBKE antisense RNA 1 (IKBKE-AS1)

IKBKE antisense RNA 1 (IKBKE-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the IKBKE gene. Antisense lncRNAs like IKBKE-AS1 are generally thought to regulate their associated sense genes through several mechanisms, such as transcriptional interference, formation of RNA-RNA duplexes, or acting as microRNA sponges to indirectly affect gene expression regulation[4]. IKBKE-AS1 itself is not a protein, receptor, enzyme, or traditional therapeutic target—rather, it may play an epigenetic or post-transcriptional regulatory role. There is currently limited information regarding its biological functions, disease involvement, or potential clinical utility.\n\nKey clarifications:\n- This entry is not the well-characterized protein kinase IKBKE (IKKε), which is a validated therapeutic target in cancer and immune disease; rather, IKBKE-AS1 refers specifically to its antisense non-coding RNA that may regulate expression of the IKBKE gene[4].\n- No current evidence supports its direct targeting by drugs, its use as a biomarker, nor any specific safety concerns or therapeutic challenges.\n- Existing references do not specify roles in any particular disease, nor assign this lncRNA to established molecular families beyond its general category as a non-coding RNA.\n\nIf you intended information about the protein kinase IKBKE (the commonly cited drug target), please clarify; IKBKE-AS1 refers specifically to its antisense RNA transcript, not the kinase itself.

Other names

IKBKE-AS1C1orf147FLJ32597IKBKE antisense RNA 1Uncharacterized protein C1orf147